NYSE ARCA | ETF
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index.
The index is comprised of global companies expected to economically benefit from weight loss drug development.
The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 14.90% |
| NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 11.98% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 11.35% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 6.65% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 6.39% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 6.07% |
| 1093 | CSPC Pharmaceutical Group Ltd | Healthcare | Drug Manufacturers - General | 5.29% |
| 1801 | Innovent Biologics Inc | Healthcare | Biotechnology | 5.27% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.26% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.22% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 5.15% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.09% |
| 4507 | Shionogi & Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 5.00% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 4.96% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.96% |
| ROP | Roche Holding AG | 4.88% | ||
| AZN_old | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.87% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.85% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.79% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.70% |